| 國家衛生研究院 |
2024-09-30 |
Registry of genetic alterations of Taiwan non-small cell lung cancer by comprehensive next-generation sequencing: A real-world cohort study-Taiwan cooperative oncology group T1521
|
Liao, BC;Chiang, NJ;Chang, GC;Su, WC;Luo, YH;Chong, IW;Yang, TY;Lai, CL;Hsia, TC;Ho, CL;Lee, KY;Hsiao, CF;Ku, FC;Fang, WT;Chih-Hsin Yang, J |
| 國立成功大學 |
2024-09 |
Registry of Genetic Alterations of Taiwan Non-Small Cell Lung Cancer by Comprehensive Next-Generation Sequencing: A Real-World Cohort Study-Taiwan Cooperative Oncology Group T1521
|
Liao;Bin-Chi;Chiang;Nai-Jung;Chang;Gee-Chen;Su;Wu-Chou;Luo;Yung-Hung;Chong;Inn-Wen;Yang;Tsung-Ying;Lai;Chun-Liang;Hsia;Te-Chun;Ho;Ching-Liang;Lee;Kang-Yun;Hsiao;Chin-Fu;Ku;Fan-Chen;Fang;Wei-Tse;Yang;James, Chih-Hsin |
| 國立臺灣大學 |
2012 |
Registry of Lipid Control and the Use of Lipid-lowering Drugs for Secondary Prevention of Cardiovascular Events in Patients with Established Atherosclerotic Disease in Taiwan: Rationality and Methods
|
Yin, Wei-Hsian; Wu, Chau-Chung; Chen, Jaw-Wen; 吳造中 |
| 國立臺灣大學 |
2012 |
Registry of Lipid Control and the Use of Lipid-lowering Drugs for Secondary Prevention of Cardiovascular Events in Patients with Established Atherosclerotic Disease in Taiwan: Rationality and Methods
|
Yin, Wei-Hsian; Wu, Chau-Chung; Chen, Jaw-Wen; 吳造中 |
| 臺大學術典藏 |
2020-03-04T09:03:12Z |
Registry of lipid control and the use of lipid-lowering drugs for secondary prevention of cardiovascular events in patients with established atherosclerotic disease in Taiwan: Rationality and methods
|
Yin W.-H.; CHAU-CHUNG WU; Chen J.-W. |
| 臺大學術典藏 |
2018-09-10T04:11:16Z |
Reglochemistry in Electrophilic Reactions of Propanedlthio-Substituted Allylic Anions Influenced by the γ-Substituents
|
JIM-MIN FANG; JIM-MIN FANG; JIM-MIN FANG |
| 國立臺灣大學 |
1992 |
Regloselective Reactions of Monosaccharides and Disaccharides by Enzymes
|
Wu, Shih-Hsiung; Ong, Geok-Toh; Hsiao, Kwo-Feng; Wang, Kung-Tsung |
| 臺大學術典藏 |
2022-08-19T00:20:30Z |
Regorafenib enhances antitumor immunity via inhibition of p38 kinase/Creb1/Klf4 axis in tumor-associated macrophages
|
Ou D.-L.; Chen C.-W.; Hsu C.-L.; Chung C.-H.; Feng Z.-R.; Lee B.-S.; Cheng A.-L.; Yang M.-H.; CHIUN HSU |
| 臺大學術典藏 |
2021-04-21T23:30:44Z |
Regorafenib enhances antitumor immunity via inhibition of p38 kinase/Creb1/Klf4 axis in tumor-associated macrophages
|
DA-LIANG OU; Chen, Chia Wei; Chia-Lang Hsu; Chung, Chih Hung; Feng, Zi Rui; Lee, Bin Shyun; ANN-LII CHENG; Yang, Muh Hwa; CHIUN HSU |
| 臺大學術典藏 |
2021-09-15T01:20:46Z |
Regorafenib enhances antitumor immunity via inhibition of p38 kinase/Creb1/Klf4 axis in tumor-associated macrophages
|
Ou D.-L.; Chen C.-W.; CHIA-LANG HSU; Chung C.-H.; Feng Z.-R.; Lee B.-S.; Cheng A.-L.; Yang M.-H.; Hsu C. |
| 臺大學術典藏 |
2022-02-08T06:27:20Z |
Regorafenib enhances antitumor immunity via inhibition of p38 kinase/Creb1/Klf4 axis in tumor-associated macrophages
|
DA-LIANG OU; Chen C.-W.; Hsu C.-L.; Chung C.-H.; Feng Z.-R.; Lee B.-S.; Cheng A.-L.; Yang M.-H.; Hsu C. |
| 臺大學術典藏 |
2022-02-21T02:04:36Z |
Regorafenib enhances antitumor immunity via inhibition of p38 kinase/Creb1/Klf4 axis in tumor-associated macrophages
|
Ou D.-L.; Chen C.-W.; Hsu C.-L.; Chung C.-H.; Feng Z.-R.; Lee B.-S.; ANN-LII CHENG; Yang M.-H.; Hsu C. |
| 國立成功大學 |
2024 |
Regorafenib for Hepatocellular Carcinoma in Real-World Practice (REFINE): A Prospective, Observational Study
|
Kim;Y, J.;Merle;P;Finn;R, S.;Kudo;M;Kl�mpen;H, -J.;Lim;H, Y.;Ikeda;M;Alessandro;A;Masi;G;G�rolami;R;Cho;S, B.;Hsu;C, -H.;Huang;Y, -H.;Jeng;L, -B.;Kim;D, Y.;Lin;S, -M.;Pinter;M;Shao;G;Kato;N;Kurosaki;M;Numata;K;Kuo;K, -K.;Mao;Y;Lin;Y, -J.;Zhu;K;Twumasi-Ankrah;P;Khan;J;Awan;M;�zg�rdal;K;Qin;S |
| 臺大學術典藏 |
2021-08-31T06:29:40Z |
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
|
Bruix J.; Qin S.; Merle P.; Granito A.; Huang Y.-H.; Bodoky G.; Pracht M.; Yokosuka O.; Rosmorduc O.; Breder V.; Gerolami R.; Masi G.; Ross P.J.; Song T.; Bronowicki J.-P.; Ollivier-Hourmand I.; Kudo M.; ANN-LII CHENG; Llovet J.M.; Finn R.S.; LeBerre M.-A.; Baumhauer A.; Meinhardt G.; Han G. |
| 臺大學術典藏 |
2021-01-28T01:06:15Z |
Regorafenib in Chinese patients with metastatic colorectal cancer: Subgroup analysis of the phase 3 CONCUR trial
|
Xu J.; Xu R.-H.; Qin S.; Pan H.; Bai Y.; Chi Y.; Wang L.; Bi F.; Cheng Y.; Liu T.; Ma D.; Shen L.; Ba Y.; Liang J.; Wang X.; Yau T.C.C.; Ma B.B.; KUN-HUEI YEH; Lin J.-K.; Kappeler C.; Shapiro J.; Kalmus J.; Li J. |
| 臺大學術典藏 |
2018-09-10T15:17:40Z |
Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): A randomised, double-blind, placebo-controlled, phase 3 trial
|
Li, J. and Qin, S. and Xu, R. and Yau, T.C.C. and Ma, B. and Pan, H. and Xu, J. and Bai, Y. and Chi, Y. and Wang, L. and Yeh, K.-H. and Bi, F. and Cheng, Y. and Le, A.T. and Lin, J.-K. and Liu, T. and Ma, D. and Kappeler, C. and Kalmus, J. and Kim, T.W.; KUN-HUEI YEH |
| 臺大學術典藏 |
2021-01-28T01:06:31Z |
Regorafenib plus best supportive care versus placebo plus best supportive care in Asian patients with previously treated metastatic colorectal cancer (CONCUR): A randomised, double-blind, placebo-controlled, phase 3 trial
|
Li J.; Qin S.; Xu R.; Yau T.C.C.; Ma B.; Pan H.; Xu J.; Bai Y.; Chi Y.; Wang L.; KUN-HUEI YEH; Bi F.; Cheng Y.; Le A.T.; Lin J.-K.; Liu T.; Ma D.; Kappeler C.; Kalmus J.; Kim T.W. |
| 國家衛生研究院 |
2022-03-10 |
Regorafenib reverses temozolomide-induced CXCL12/CXCR4 signaling and triggers apoptosis mechanism in glioblastoma
|
Chiang, IT;Liu, YC;Liu, HS;Ali, AAA;Chou, SY;Hsu, TI;Hsu, FT |
| 國立交通大學 |
2014-12-08T15:36:08Z |
RegPhos 2.0: an updated resource to explore protein kinase-substrate phosphorylation networks in mammals
|
Huang, Kai-Yao; Wu, Hsin-Yi; Chen, Yi-Ju; Lu, Cheng-Tsung; Su, Min-Gang; Hsieh, Yun-Chung; Tsai, Chih-Ming; Lin, Kuo-I; Huang, Hsien-Da; Lee, Tzong-Yi; Chen, Yu-Ju |
| 元智大學 |
2014-4-1 |
RegPhos 2.0: an updated resource to explore protein kinase-substrate phosphorylation networks in mammals
|
Kai-Yao Huang; Hsin-Yi Wu; Yi-Ju Chen; Cheng-Tsung Lu; Min-Gang Su; Yun-Chung Hsieh; Chih-Ming Tsai; Kuo-I Lin; Hsien-Da Huang; Tzong-Yi Lee; Yu-Ju Chen |
| 元智大學 |
2014-4-1 |
RegPhos 2.0: an updated resource to explore protein kinase-substrate phosphorylation networks in mammals
|
Kai-Yao Huang; Hsin-Yi Wu; Yi-Ju Chen; Cheng-Tsung Lu; Min-Gang Su; Yun-Chung Hsieh; Chih-Ming Tsai; Kuo-I Lin; Hsien-Da Huang; Tzong-Yi Lee; Yu-Ju Chen |
| 元智大學 |
2014-4-1 |
RegPhos 2.0: an updated resource to explore protein kinase-substrate phosphorylation networks in mammals
|
Kai-Yao Huang; Hsin-Yi Wu; Yi-Ju Chen; Cheng-Tsung Lu; Min-Gang Su; Yun-Chung Hsieh; Chih-Ming Tsai; Kuo-I Lin; Hsien-Da Huang; Tzong-Yi Lee; Yu-Ju Chen |
| 國立交通大學 |
2014-12-08T15:37:55Z |
RegPhos: a system to explore the protein kinase-substrate phosphorylation network in humans
|
Lee, Tzong-Yi; Hsu, Justin Bo-Kai; Chang, Wen-Chi; Huang, Hsien-Da |
| 元智大學 |
2011-01 |
RegPhos: a system to explore the protein kinase-substrate phosphorylation network in humans
|
Tzong-Yi Lee; Justin Bo-Kai Hsu; Wen-Chi Chang; Hsien-Da Huang |
| 國立成功大學 |
2011-01 |
RegPhos: a system to explore the protein kinase-substrate phosphorylation network in humans
|
Lee, Tzong-Yi; Hsu, Justin Bo-Kai; Chang, Wen-Chi; Huang, Hsien-Da |
| 國立交通大學 |
2014-12-08T15:12:44Z |
Regression analysis based on semicompeting risks data
|
Hsieh, Jin-Jian; Wang, Weijing; Ding, A. Adam |
| 國立政治大學 |
2017-01 |
Regression analysis for bivariate gap time with missing first gap time data
|
黃佳慧; Huang, C.-H.; Chen, Y.-H. |
| 國立交通大學 |
2014-12-08T15:09:42Z |
REGRESSION ANALYSIS FOR CUMULATIVE INCIDENCE PROBABILITY UNDER COMPETING RISKS
|
Chang, Wei-Hwa; Wang, Weijing |
| 東海大學 |
2012 |
Regression analysis for cumulative incidence probability under competing risks and left-truncated sampling
|
Shen, P.-S. |
| 淡江大學 |
2009-06-26 |
Regression analysis for multivariate current status data
|
陳蔓樺 |
| 國立交通大學 |
2014-12-08T15:27:17Z |
Regression Analysis for Recurrent Events Data under Dependent Censoring
|
Hsieh, Jin-Jian; Ding, A. Adam; Wang, Weijing |
| 中原大學 |
2009-10 |
Regression Analysis for the Climate Effects on Seasonal Variations in the Urinary Lithotripsy: A Regional Hospital Based Study
|
Liu, S.; Chen, H. |
| 亞洲大學 |
2005 |
Regression analysis for the sorption isotherms of basic dyes on sugarcane dust
|
Ho, Y.S.;Chiu, W.T.;Wang, C.C. |
| 東海大學 |
2013 |
Regression analysis of interval censored and doubly truncated data with linear transformation models
|
Shen, P.-S. |
| 淡江大學 |
2014-07 |
Regression analysis of mixed recurrent-event and panel-count data
|
Zhu, Liang; Tong, Xinwei; Sun, Jianguo; Chen, Man-Hua; Deo Kumar Srivastava; Wendy Leisenring; Leslie L. Robison |
| 中原大學 |
2000-01 |
Regression analysis of multivariate binary response variables using Rasch-type models and finite-mixture methods
|
G. Arminger;C.C. Clogg;T. Cheng |
| 中山醫學大學 |
2015 |
Regression analysis of multivariate current status data with auxiliary covariates under the additive hazards model
|
YurongChen; YanqinFeng; JianguoSun |
| 淡江大學 |
2008-06 |
Regression Analysis of Multivariate Interval-Censored FailureTime Data with Application to Tumorigenicity Experiments
|
Chen, Man-Hua; Tong, Xingwei; Sun, Jian-guo |
| 淡江大學 |
2025 |
Regression analysis of randomized response event time data
|
Wen, C. C. |
| 國家衛生研究院 |
2007 |
Regression diagnostic under model misspecification
|
Chien, LC; Tsou, TS |
| 淡江大學 |
2013 |
Regression diagnostics for current status data using the odds-rate model
|
洪筱涵; Hung, Hsiao-Han |
| 淡江大學 |
2014-08-05 |
Regression Diagnostics for Current Status Data Using the Odds-Rate Model
|
Wen, Chi-Chung |
| 東海大學 |
2013 |
Regression M-estimators with one modified form of doubly censored data
|
Shen, P.-S. |
| 中原大學 |
1995-01 |
Regression Madels for Ordinal, Partially Ordinal, Scaled, and Partially Sacled discrete Rrsponse Variables.
|
T. Cheng |
| 中原大學 |
1997 |
Regression Methods for Oridinal Categoritcal Response
|
T. Cheng |
| 國立臺灣大學 |
2002 |
Regression modeling for nonparametric estimation of distribution and quantile functions
|
Cheng, M.-Y.; Peng, L. |
| 中國醫藥大學 |
2007-05-05 |
Regression of Dilated Cardiomyopathy after Switching Iron Chelator from Deferoxamine (DFX) to Deferiprone (L1)
|
張正成(Jeng-Sheng Chang); (Yu C. Huang); (Kang H. Wu); (Ching T. Peng); 蘇百弘(Bai-Horng Su); 葉純甫* |
| 中國醫藥大學 |
2006-10-31 |
Regression of dilated cardiomyopathy after switching iron chelator from deferoxamine (DFX) to deferiprone (L1)
|
莊子瑤(Tzu-Yao Chuang); 張正成(Jeng-Sheng Chang)*; 黃有志(Yu-Chih Huang); 巫康熙(Kang-His Wu); 彭慶添(Ching-Tien Peng); 莊子瑤(Tzu-Yao Chuang) |
| 中國醫藥大學 |
2006-10 |
Regression of dilated cardiomyopathy after switching iron chelator from deferoxamine to deferiprone
|
張正成(Jeng-Sheng Chang); 黃有志(Yu-Chih Huang); 巫康熙(Kang-Hsi Wu); 彭慶添(Ching-Tien Peng) |
| 中國醫藥大學 |
2007-05 |
Regression of dilated cardiomyopathy after switching iron chelator from deferoxamine(DFX) to deferiprone.
|
張正成(Jeng-Sheng Chang); 黃有志(You-Chih Huang); 巫康熙(Kang-His Wu); 彭慶添(Ching-Tien Peng); 葉純甫(Chun-Fu Yeh) |
